Gadolinium-based contrast agents (GBCAs) are widely used in clinical practice. However, there are growing concerns regarding the safety of GBCAs with recent findings of gadolinium deposition in patients with normal renal function. This educational exhibit reviews the use of gadolinium in children, including the safety profile, existing controversies, and potential solutions. Read More

Meeting name: SPR 2017 Annual Meeting & Categorical Course , 2017

Authors: Lam Christopher, Chavhan Govind

Keywords: nephrogenic systemic fibrosis, gadolinium deposition disease, gadolinium toxicity